The Use of Ketamine for Malignant and Nonmalignant Chronic Pain in Children: A Review of Current Evidence

References

• Sheehy KA, Muller EA, Lippold C, Nouraie M, Finkel JC, Quezado ZMN. Subanesthetic ketamine infusions for the treatment of children and adolescents with chronic pain: a longitudinal study. BMC Pediatr. 2015;15(1):198. doi:10.1186/s12887-015-0515-4.
   PubMedGoogle Scholar
• Niesters M, Martini C, Dahan A. Ketamine for chronic pain: risks and benefits. Br J Clin Pharmacol. 2013;77(2):357–67. doi:10.1111/bcp.12094.
   Web of Science ®Google Scholar
• Nowacka A, Borczyk M. Ketamine applications beyond anesthesia – A literature review. Eur J Pharmacol. 2019;860:172547. doi:10.1016/j.ejphar.2019.172547.
   PubMed Web of Science ®Google Scholar
• Chang C, McDonnell P, Gershwin ME. Complex regional pain syndrome – False hopes and miscommunications. Autoimmun Rev. 2019;18(3):270–8. doi:10.1016/j.autrev.2018.10.003.
   PubMed Web of Science ®Google Scholar
• Courade M, Bertrand A, Guerrini-Rousseau L, Pagnier A, Levy D, Lervat C, Cojean N, Ribrault A, Dugue S, Thouvenin S, et al. Low-dose ketamine adjuvant treatment for refractory pain in children, adolescents and young adults with cancer: a pilot study. BMJ Support Palliat Care. 2022;12(e5):e656–e663. doi:10.1136/bmjspcare-2018-001739.
   PubMed Web of Science ®Google Scholar
• Vadivelu N, Schermer E, Kodumudi V, Belani K, Urman RD, Kaye AD. Role of ketamine for analgesia in adults and children. J Anaesthesiol Clin Pharmacol. 2016;32(3):298–306. doi:10.4103/0970-9185.168149.
   PubMedGoogle Scholar
• Morgan CJA, Curran HV; Independent Scientific Committee on Drugs. Ketamine use: a review. Addiction. 2011;107(1):27–38. doi:10.1111/j.1360-0443.2011.03576.x.
   PubMed Web of Science ®Google Scholar
• Aroni F, Iacovidou N, Dontas I, Pourzitaki C, Xanthos T. Pharmacological aspects and potential new clinical applications of ketamine: reevaluation of an old drug. J Clin Pharmacol. 2009;49(8):957–64. doi:10.1177/0091270009337941.
   PubMed Web of Science ®Google Scholar
• Li L, Vlisides PE. Ketamine: 50 years of modulating the mind. Front Hum Neurosci. 2016;10:612. doi:10.3389/fnhum.2016.00612.
   PubMed Web of Science ®Google Scholar
• Bredlau A-L, McDermott MP, Adams HR, Dworkin RH, Venuto C, Fisher SG, Dolan JG, Korones DN. Oral ketamine for children with chronic pain: a pilot phase 1 study. J Pediatr. 2013;163(1):194–200.e1. doi:10.1016/j.jpeds.2012.12.077.
   PubMed Web of Science ®Google Scholar
• Yamani N, Olesen J. New daily persistent headache: a systematic review on an enigmatic disorder. J Headache Pain. 2019;20(1):80. doi:10.1186/s10194-019-1022-z.
   PubMedGoogle Scholar
• Cohen SP, Bhatia A, Buvanendran A, Schwenk ES, Wasan AD, Hurley RW, Viscusi ER, Narouze S, Davis FN, Ritchie EC, et al. Consensus guidelines on the use of intravenous ketamine infusions for chronic pain from the american society of regional anesthesia and pain medicine, the american academy of pain medicine, and the american society of anesthesiologists. Reg Anesth Pain Med. 2018;43(5):521–46. doi:10.1097/aap.0000000000000808.
   PubMed Web of Science ®Google Scholar
• Peltoniemi MA, Hagelberg NM, Olkkola KT, Saari TI. Ketamine: a review of clinical pharmacokinetics and pharmacodynamics in anesthesia and pain therapy. Clin Pharmacokinet. 2016;55(9):1059–77. doi:10.1007/s40262-016-0383-6.
   PubMed Web of Science ®Google Scholar
• Orhurhu VJ, Vashisht R, Claus LE, Cohen SP. Ketamine toxicity. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023.
   Google Scholar
• Lin C, Durieux ME. Ketamine and kids: an update. Paediatr Anaesth. 2005;15(2):91–7. doi:10.1111/j.1460-9592.2005.01475.x.
   PubMed Web of Science ®Google Scholar
• Prakash S, Gupta AK, Meena JP, Seth R. A review of the clinical applications of ketamine in pediatric oncology. Pediatr Blood Cancer. 2020;68(1):e28785. doi:10.1002/pbc.28785.
   PubMed Web of Science ®Google Scholar
• Dong C, Anand KJS. Developmental neurotoxicity of ketamine in pediatric clinical use. Toxicol Lett. 2013;220(1):53–60. doi:10.1016/j.toxlet.2013.03.030.
   PubMed Web of Science ®Google Scholar
• Visser E, Schug SA. The role of ketamine in pain management. Biomed Pharmacother. 2006;60(7):341–8. doi:10.1016/j.biopha.2006.06.021.
   PubMed Web of Science ®Google Scholar
• Bredlau AL. Neurocognitive changes after sustained ketamine administration in children with chronic pain. J. Palliat. Med. 2015;5(2):215. doi:10.4172/2165-7386.1000215.
   Google Scholar
• Borsook D. Ketamine and chronic pain – Going the distance. Pain. 2009;145(3):271–2. doi:10.1016/j.pain.2009.05.021.
   PubMed Web of Science ®Google Scholar
• Laumet G, Chen SR, Pan HL. 2017. NMDA receptors and signaling in chronic neuropathic pain. In: Hashimoto, K. editor. The NMDA receptors. Vol 30. Cham: Humana Press. doi:10.1007/978-3-319-49795-2_6.
   Google Scholar
• Anderson BJ, Palmer GM. Recent developments in the pharmacological management of pain in children. Curr Opin Anaesthesiol. 2006;19(3):285–92. doi:10.1097/01.aco.0000192802.33291.6f.
   PubMed Web of Science ®Google Scholar
• Hocking G, Cousins MJ. Ketamine in chronic pain management: an evidence-based review. Anesth Analg. 2003;97(6):1730–9. doi:10.1213/01.ANE.0000086618.28845.9B.
   PubMed Web of Science ®Google Scholar
• Anghelescu DL, Tesney JM. Neuropathic pain in pediatric oncology: a clinical decision algorithm. Paediatr Drugs. 2019;21(2):59–70. doi:10.1007/s40272-018-00324-4.
   PubMed Web of Science ®Google Scholar
• Bredlau AL, Thakur R, Korones DN, Dworkin RH. Ketamine for pain in adults and children with cancer: a systematic review and synthesis of the Literature. Pain Med. 2013;14(10):1505–17. doi:10.1111/pme.12182.
   PubMed Web of Science ®Google Scholar
• Friedrichsdorf SJ, Kang TI. The management of pain in children with life-limiting illnesses. Pediatr. Clin. N. Am. 2007;54(5):645–72. doi:10.1016/j.pcl.2007.07.007.
   PubMed Web of Science ®Google Scholar
• Bali A, Dang AK, Gonzalez DA, Kumar R, Asif S. Clinical uses of ketamine in children: a narrative review. Cureus. 2022;14(7):e27065. doi:10.7759/cureus.27065.
   PubMed Web of Science ®Google Scholar
• Dolansky G, Shah A, Mosdossy G, Rieder M. What is the evidence for the safety and efficacy of using ketamine in children? Paediatr Child Health. 2008;13(4):307–8. doi:10.1093/pch/13.4.307.
   PubMed Web of Science ®Google Scholar
• Wang C, Zheng D, Xu J, Lam W, Yew DT. Brain damage in ketamine addicts as revealed by magnetic resonance imaging. Front Neuroanat. 2013;7:23. doi:10.3389/fnana.2013.00023.
   PubMed Web of Science ®Google Scholar
• Green SM, Coté CJ. Ketamine and neurotoxicity: clinical perspectives and implications for emergency medicine. Ann Emerg Med. 2009;54(2):181–90. doi:10.1016/j.annemergmed.2008.10.003.
   PubMed Web of Science ®Google Scholar
• Finkel JC, Pestieau SR, Quezado ZMN. Ketamine as an adjuvant for treatment of cancer pain in children and adolescents. J Pain. 2007;8(6):515–21. doi:10.1016/j.jpain.2007.02.429.
   PubMed Web of Science ®Google Scholar
• Snaman JM, Baker JN, Ehrentraut JH, Anghelescu DL. Pediatric oncology: managing pain at the end of life. Paediatr Drugs. 2016;18(3):161–80. doi:10.1007/s40272-016-0168-2.
   PubMed Web of Science ®Google Scholar
• Taylor M, Jakacki R, May C, Howrie D, Maurer S. Ketamine PCA for treatment of end-of-life neuropathic pain in pediatrics. Am J Hosp Palliat Care. 2015;32(8):841–8. doi:10.1177/1049909114543640.
   PubMed Web of Science ®Google Scholar
• Prakash S, Meena JP, Gupta AK, Bakhshi S, Velpandian T, Pandey RM, Seth R. Ketamine mouthwash versus placebo in the treatment of severe oral mucositis pain in children with cancer: a randomized double-blind placebo-controlled trial. Pediatr Blood Cancer. 2020;67(9):e28573. doi:10.1002/pbc.28573.
   PubMed Web of Science ®Google Scholar
• Fallon MT, Wilcock A, Kelly CA, Paul J, Lewsley LA, Norrie J, Laird BJA. Oral ketamine vs. placebo in patients with cancer-related neuropathic pain. JAMA Oncol. 2018;4(6):870–2. doi:10.1001/jamaoncol.2018.0131.
   PubMed Web of Science ®Google Scholar
• Hardy J, Quinn S, Fazekas B, Plummer J, Eckermann S, Agar M, Spruyt O, Rowett D, Currow DC. Randomized, double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer pain. J Clin Oncol. 2012;30(29):3611–7. doi:10.1200/JCO.2012.42.1081.
   PubMed Web of Science ®Google Scholar
• Jonkman K, Van De Donk T, Dahan A. Ketamine for cancer pain: what is the evidence? Curr Opin Support Palliat Care. 2017;11(2):88–92. doi:10.1097/SPC.0000000000000262.
   PubMed Web of Science ®Google Scholar
• Conway M, White N, Jean CS, Zempsky WT, Steven K. Use of continuous intravenous ketamine for end-stage cancer pain in children. J Pediatr Oncol Nurs. 2009;26(2):100–6. doi:10.1177/1043454208328768.
   PubMed Web of Science ®Google Scholar
• Mathew E, Kim E, Goldschneider KR. Pharmacological treatment of chronic non-cancer pain in pediatric patients. Paediatr Drugs. 2014;16(6):457–71. doi:10.1007/s40272-014-0092-2.
   PubMed Web of Science ®Google Scholar
• Sheehy KA, Lippold C, Rice AL, Nobrega R, Finkel JC, Quezado ZM. Subanesthetic ketamine for pain management in hospitalized children, adolescents, and young adults: a single-center cohort study. J Pain Res. 2017;10:787–95. doi:10.2147/jpr.s131156.
   PubMed Web of Science ®Google Scholar
• Masaracchia MM, Sites BD, Lee J, Thomas JJ, Fernandez PG. Subanesthetic ketamine infusions for the management of pediatric pain in non-critical care settings: an observational analysis. Acta Anaesthesiol Scand. 2019;63(9):1225–30. doi:10.1111/aas.13429.
   PubMed Web of Science ®Google Scholar
• Michelet D, Hilly J, Skhiri A, Abdat R, Diallo T, Brasher C, Dahmani S. Opioid-sparing effect of ketamine in children: a meta-analysis and trial sequential analysis of published studies. Paediatr Drugs. 2016;18(6):421–33. doi:10.1007/s40272-016-0196-y.
   PubMed Web of Science ®Google Scholar